| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10968634 | Vaccine | 2013 | 15 Pages |
Abstract
⺠A suitable adjuvant is needed to improve the efficacy of antileishmanial vaccines. ⺠Particulate adjuvants are the valuable strategy to enhance vaccine efficacies. ⺠The most challenging issue in the field of particulate adjuvants is their size. ⺠Liposomes plus immunostimulatory adjuvants are prospective antileishmanial vaccines.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Ali Badiee, Vahid Heravi Shargh, Ali Khamesipour, Mahmoud Reza Jaafari,